ClinVar Miner

Submissions for variant NM_000518.4(HBB):c.422C>A (p.Ala141Asp)

dbSNP: rs33927093
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000757357 SCV000885550 uncertain significance not specified 2018-11-09 criteria provided, single submitter clinical testing The HBB c.422C>A; Ala140Asp variant (rs33927093), also known as Hb Himeji, has been reported in the heterozygous state in individuals with no clinical symptoms (HbVar database and references therein). However, its phenotype when found with other pathogenic globin variants is unknown, and the reported percentage of Hb X by hemoglobin electrophoresis in the presence of Hb Himeji ranges from 21-44% (HbVar database, Martins 1989, Ohba 1986), so this structural variant may be unstable. This variant is listed in ClinVar (Variation ID: 15197), but is absent from general population databases (1000 Genomes Project, Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The alanine at residue 140 is highly conserved, and computational algorithms (SIFT, PolyPhen-2) predict that this variant is deleterious. Additionally, other variants at this codon (c.421G>A, p.Ala140Thr, Hb Saint-Jacques; c.422C>T, p.Ala140Val, Hb Puttelange) have been reported the heterozygous state in individuals with erythrocytosis (HbVar database and references therein). Due to limited information, the clinical significance of the Hb Himeji variant is uncertain at this time. References: Link to HbVar database for Hb Himeji: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=556 Link to HbVar database for Hb Saint-Jacques: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=555&.cgifields=histD Link to HbVar database for Hb Puttelange: http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=output&display_format=page&i=557&.cgifields=histD Martins MC et al. Hb Himeji or alpha 2 beta 2(140)(H18)Ala----Asp in a Portuguese family. Hemoglobin. 1989;13(4):411-5. Ohba Y et al. Hb Himeji or beta 140 (H18) Ala----Asp. A slightly unstable hemoglobin with increased beta N-terminal glycation. Hemoglobin. 1986;10(2):109-25.
OMIM RCV000016380 SCV000036648 other HEMOGLOBIN HIMEJI 2017-12-12 no assertion criteria provided literature only
Natera, Inc. RCV001277081 SCV001463829 uncertain significance beta Thalassemia 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.